Could a Parkinson's pill rekindle lost interests?
NCT ID NCT05182151
Summary
This study aimed to see if an already-approved Parkinson's disease medication called istradefylline could help improve motivation and reduce apathy—a common symptom where people lose interest in activities. It planned to test this over 12 weeks in a small group of people with Parkinson's who were already taking levodopa and had significant 'off' time. The study was terminated early, so its full results are not available.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
MUSC Movement Disorders Program
Charleston, South Carolina, 29425, United States
Conditions
Explore the condition pages connected to this study.